SCHEMBL3554338

SCHEMBL3554338

COc1cccc2c1OCC=CC2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 1/20 0.37
DRD2 P14416 2/20 0.36
DRD1 P21728 2/20 0.36
DRD5 P21918 2/20 0.36
DRD3 P35462 2/20 0.36
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA4 P22748 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
CA14 Q9ULX7 1/20 0.35
ALDH1A1 P00352 2/20 0.34
MAPT P10636 2/20 0.34
HPGD P15428 2/20 0.34
DRD4 P21917 1/20 0.34
KDM4E B2RXH2 1/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7520140 0.74 KMT2A (0.43) CA12CA1CA2CA4CA7
SCHEMBL5785526 0.73 PARP1 (0.47) HTR7DRD2DRD1DRD5DRD3
SCHEMBL506157 0.72 DRD2 (0.46) DRD2DRD1DRD5DRD3CA12
SCHEMBL11106287 0.70 TERT (0.38) HTR7CA12CA1CA2CA4
SCHEMBL30465990 0.70 ACHE (0.43) HTR7DRD2DRD3ALDH1A1MAPT
SCHEMBL1896596 0.70 MEN1 (0.37) ALDH1A1LMNA
SCHEMBL7516624 0.70 ACHE (0.43) HTR7DRD2DRD3ALDH1A1MAPT
SCHEMBL13681724 0.69 DRD2 (0.47) DRD2DRD1DRD5DRD3ALDH1A1
SCHEMBL7363824 0.68 TERT (0.42) CA12CA9ALDH1A1MAPTHPGD
SCHEMBL12992638 0.67 DRD1 (0.44) DRD2DRD1DRD5DRD3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7691843-B2 N-hydroxyamide derivatives possessing antibacterial activity PFIZER INC. (US) 2010-04-06 US claimed
US-20080058304-A1 N-hydroxyamide derivatives possessing antibacterial activity VICURON HOLDINGS LLC 2008-03-06 US claimed
US-7691843-B2 N-hydroxyamide derivatives possessing antibacterial activity PFIZER INC. (US) 2010-04-06 US disclosed
US-20080058304-A1 N-hydroxyamide derivatives possessing antibacterial activity VICURON HOLDINGS LLC 2008-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058304-A1 N-hydroxyamide derivatives possessing antibacterial activity AMDHD2, OGA, ENGASE HTR7 1720/4885DRD2 1525/4885DRD1 1812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.